Verition Fund Management’s Strata Critical Medical Inc SRTA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-92,701
Closed -$446K 2389
2025
Q4
$446K Buy
92,701
+9,800
+12% +$47.4K ﹤0.01% 2751
2025
Q3
$419K Buy
82,901
+54,017
+187% +$239K ﹤0.01% 3125
2025
Q2
$116K Buy
+28,884
New +$94K ﹤0.01% 3466
2024
Q3
Sell
-11,502
Closed -$40K 3199
2024
Q2
$40K Buy
+11,502
New +$38.4K ﹤0.01% 2811
2023
Q4
Sell
-19,443
Closed -$50.4K 2350
2023
Q3
$50.4K Buy
+19,443
New +$68.3K ﹤0.01% 2186

Other funds holding SRTA

Verition Fund Management's SRTA Position: Q1 2026 in Review

Verition Fund Management sold out of Strata Critical Medical Inc (SRTA) in Q1 2026, closing a stake of 92,701 shares — an estimated $446K sold.

Verition Fund Management first reported a position in SRTA in Q3 2023 and held it in 5 quarters. The position peaked at $446K in Q4 2025. 125 funds tracked by Wall St. Rank hold SRTA as of Q1 2026.

  • Verition Fund Management reported no remaining Strata Critical Medical Inc position as of Q1 2026 after selling out during the quarter.
  • Verition Fund Management sold 92,701 Strata Critical Medical Inc shares in Q1 2026, an estimated $446K.
  • Verition Fund Management first reported a position in Strata Critical Medical Inc in Q3 2023 and held it in 5 quarters.
  • Verition Fund Management's Strata Critical Medical Inc position peaked at $446K in Q4 2025.
  • 125 funds tracked by Wall St. Rank held Strata Critical Medical Inc as of Q1 2026.

Based on Verition Fund Management's 13F filing for Q1 2026, filed 15 May 2026.